Epigenomics Program, Broad Institute

United States of America (USA)

1 December 2019 - 30 November 2020

No articles found. Epigenomics Program, Broad Institute did not contribute to any primary research papers from Nature Index journals in the current 12 month window.

Broad Institute of MIT and Harvard

↳ Epigenomics Program, Broad Institute

Broad Institute Cell Circuits Program

Broad Institute Centers for Mendelian Genomics (CMG)

Broad Metabolism Program (BMP), Broad Institute

Broad Technology Labs (BTL), Broad Institute

Cancer Area, Broad Institute

Cancer Team, Broad Institute

Cardiovascular Disease Initiative (CVDi), Broad Institute

Chemical Biology and Therapeutics Science Program (CBTS), Broad Institute

Broad Center for the Development of Therapeutics (CDoT)

Center for the Science of Therapeutics (CSofT), Broad Institute

Computational Biology and Bioinformatics Program, Broad Institute

Data Sciences Platform (DSP), Broad Institute

Genetic Perturbation Platform, Broad Institute

Genomics Platform, Broad Institute

Imaging Platform, Broad Institute

Infectious Disease and Microbiome Program, Broad Institute

Klarman Cell Observatory, Broad Institute

Merkin Institute of Transformative Technologies in Healthcare, Broad Institute

Metabolomics Platform, Broad Institute

Program in Medical and Population Genetics, Broad Institute

Proteomics Platform, Broad Institute

Stanley Center for Psychiatric Research, Broad Institute

Return to institution outputs

Latest supplement

Nature Index 2020 Artificial Intelligence

Artificial intelligence is one of the most rapidly advancing and controversial topics in scientific research. As investments and revenues soar year-on-year and nations vie for leadership in the field, AI research output continues its steep, upward trajectory. But there are significant ethical and technical challenges to overcome.

Access free